Coagulation Factor IX antibody (AA 217-423)
Quick Overview for Coagulation Factor IX antibody (AA 217-423) (ABIN1886209)
Target
See all Coagulation Factor IX (F9) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 217-423
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 217 and 423 of Human F9
-
-
-
-
Application Notes
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.250 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 20 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- Coagulation Factor IX (F9)
-
Alternative Name
- Factor IX
-
Background
-
This gene encodes vitamin K-dependent coagulation factor IX that circulates in the blood as an inactive zymogen.This factor is converted to an active form by factor XIa, which excises the activation peptide and thus generates a heavy chain and a light chain held together by one or more disulfide bonds.The role of this activated factor IX in the blood coagulation cascade is to activate factor X to its active form through interactions with Ca+2 ions, membrane phospholipids, and factor VIII.Alterations of this gene, including point mutations, insertions and deletions, cause factor IX deficiency, which is a recessive X-linked disorder, also called hemophilia B or Christmas disease.[provided by RefSeq]
-
Molecular Weight
- 52 kDa
-
Gene ID
- 2158
Target
-